Literature DB >> 17875387

Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats.

Mahmoud Hosseini1, S Mohammad Shafiee, Tourandokht Baluchnejadmojarad.   

Abstract

The rennin-angiotensin system (RAS) has been implicated in the development of diabetic vascular complications. Peptidyl-dipeptidase A (angiotensin converting enzyme, ACE) has a major role in this system. The aim of the present study was to clarify the effect of intraperitoneal administration of aqueous garlic extract (Allium sativum) on the serum ACE activity of streptozotocin (STZ)-diabetic and nondiabetic rats. Although garlic extract administration had no significant effect on serum glucose, it significantly strongly decreased the serum ACE activity. ACE activity was higher in diabetic than nondiabetic rats, but in diabetic animals treated with garlic extract, the elevation of ACE activity did not occur. These results suggest that garlic extract might have value as ACE inhibitor to prevent some vascular complications of diabetes mellitus.

Entities:  

Year:  2007        PMID: 17875387     DOI: 10.1016/j.pathophys.2007.07.002

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  11 in total

1.  Garlic (Allium sativum) down-regulates the expression of angiotensin II AT(1) receptor in adrenal and renal tissues of streptozotocin-induced diabetic rats.

Authors:  Mohamed H Mansour; Khaled Al-Qattan; Martha Thomson; Muslim Ali
Journal:  Inflammopharmacology       Date:  2012-05-30       Impact factor: 4.473

Review 2.  Chinese medicine for treating diabetic nephropathy.

Authors:  Bin Wang; Lan Lin; Qing Ni; Cheng-lian Su
Journal:  Chin J Integr Med       Date:  2013-03-26       Impact factor: 1.978

3.  Hydroalcoholic extract of Allium eriophyllum leaves attenuates cardiac impairment in rats with simultaneous type 2 diabetes and renal hypertension.

Authors:  Z Janahmadi; A A Nekooeian; M Mozafari
Journal:  Res Pharm Sci       Date:  2015 Mar-Apr

4.  Evaluation of polyherbal formulation (SJT-HT-03) for antihypertensive activity in albino rats.

Authors:  Hardik S Ghelani; Bipin M Patel; Rina H Gokani; Manish A Rachchh
Journal:  Ayu       Date:  2014 Oct-Dec

5.  Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease.

Authors:  Ehécatl M A García-Trejo; Abraham S Arellano-Buendía; Raúl Argüello-García; María L Loredo-Mendoza; Fernando E García-Arroyo; Mónica G Arellano-Mendoza; María C Castillo-Hernández; Gustavo Guevara-Balcázar; Edilia Tapia; Laura G Sánchez-Lozada; Horacio Osorio-Alonso
Journal:  Oxid Med Cell Longev       Date:  2016-11-21       Impact factor: 6.543

6.  The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.

Authors:  Ehécatl Miguel Ángel García Trejo; Abraham Said Arellano Buendía; Omegar Sánchez Reyes; Fernando Enrique García Arroyo; Raúl Arguello García; María Lilia Loredo Mendoza; Edilia Tapia; Laura Gabriela Sánchez Lozada; Horacio Osorio Alonso
Journal:  Int J Mol Sci       Date:  2017-09-16       Impact factor: 5.923

7.  Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats.

Authors:  Harikesh Dubey; Anamika Singh; Angad M Patole; Chandrashekhar R Tenpe
Journal:  Integr Med Res       Date:  2016-12-16

Review 8.  Potential angiotensin converting enzyme (ACE) inhibitors from Iranian traditional plants described by Avicenna's Canon of Medicine.

Authors:  Seyede Zohre Kamrani Rad; Behjat Javadi; A Wallace Hayes; Gholamreza KarimI
Journal:  Avicenna J Phytomed       Date:  2019 Jul-Aug

9.  The Effect of Ascorbic Acid and Garlic Administration on Lead-Induced Neural Damage in Rat Offspring's Hippocampus.

Authors:  Akram Sadeghi; Alireza Ebrahimzadeh Bideskan; Fatemeh Alipour; Alireza Fazel; Hossein Haghir
Journal:  Iran J Basic Med Sci       Date:  2013-02       Impact factor: 2.699

10.  Garlic Attenuates Plasma and Kidney ACE-1 and AngII Modulations in Early Streptozotocin-Induced Diabetic Rats: Renal Clearance and Blood Pressure Implications.

Authors:  Khaled K Al-Qattan; Martha Thomson; Divya Jayasree; Muslim Ali
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.